manufactured · input

Plastic Ports, Overcaps, and Closure Components

Injection ports, administration set spike ports, additive ports, and overwrap overcaps made from medical-grade PP, PE, or polyisoprene. Typically sole-sourced per product design — changing a port requires FDA supplement filing. Even if bag film is available, port supply disruption can independently halt production of specific product codes.

5

Source countries

3

Companies

1

Goods affected

0

Claims on record

What depends on it

Goods that need this input

1 essential American goods rely on plastic ports, overcaps, and closure components somewhere upstream in their supply chain.

Where it comes from

Source countries

Share of global supply, by country.

CountryShare of supply
USUnited States35%
DEGermany20%
CHSwitzerland15%
CNChina15%
FRFrance8%

Who makes it

Supplier companies

3 companies produce plastic ports, overcaps, and closure components.

West Pharmaceutical Services, Inc.

HQ US35% shareSOLE SUPPLIER

American pharmaceutical packaging components company (NYSE: WST, HQ Exton PA; ~$3B revenue); world's leading manufacturer of drug packaging components including rubber stoppers, seals, and plastic closure systems for vials, syringes, IV bags, and drug cartridges. West Pharma's Daikyo Crystal Zenith® plastic components and SmartDose® electronic drug delivery systems are used by virtually every major pharmaceutical company. For IV bags, West supplies elastomeric injection ports, administration set connectors, and additive port caps. West Pharmaceutical Services benefited enormously from the COVID-19 vaccine rollout — its rubber stoppers seal vaccine vials; the company's stock rose ~4x from 2019 to 2022 as vaccine production surged. West also operates a joint venture with Daikyo Seiko (Japan) — producer of Crystal Zenith cyclic olefin polymer (COP) syringes and vials used for sensitive biologics. The same Pennsylvania company that makes the little rubber stopper in your flu shot vial also makes the port components on IV bags and the closure systems for insulin cartridges.

Datwyler Holding AG (Pharma Solutions)

HQ CH20% shareSOLE SUPPLIER

Swiss industrial components conglomerate (SIX: DAE, HQ Altdorf, Uri; ~CHF 1.5B revenue); Datwyler Pharma Solutions division produces pharmaceutical elastomeric closures (rubber stoppers, plungers) and plastic components for IV bags, syringes, and vials via its Helvoet Pharma and Datwyler operations. Datwyler operates cleanroom rubber vulcanization and plastic injection molding facilities in Belgium, France, Germany, US, and Asia. Uri canton in Switzerland — where Datwyler is headquartered — is the historic canton of William Tell, the legendary Swiss freedom fighter. The canton that produced the founding myth of Swiss independence now produces the rubber closures and plastic ports used in hospital IV bags worldwide.

Aptar Pharma(ATR)

HQ US12% shareSOLE SUPPLIER

American drug delivery and packaging company (NYSE: ATR, HQ Crystal Lake IL; ~$3.5B revenue); Aptar Pharma division produces drug delivery devices and components including injectable drug delivery systems, needle-free injection components, and parenteral packaging. For IV bag applications, Aptar supplies injection site components and additive port systems. Aptar also produces metered-dose inhaler (MDI) valves for asthma inhalers (a major product line), nasal spray pumps, and eye dropper closures. The same Aptar company that makes the pumping mechanism in your nasal allergy spray also supplies components for IV bag injection ports.